This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Primary Cutaneous B-cell Lymphoma
Information about Primary Cutaneous B-cell Lymphoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Primary Cutaneous B-cell Lymphoma
Most recent studies have shown that Primary Cutaneous B-cell Lymphoma shares some biological mechanisms with b-cell-lymphomas, cutaneous-b-cell-non-hodgkin-lymphoma, dermatologic-disorders, diffuse-large-b-cell-lymphoma, lyme-disease, lymphoma, lymphoma-follicular, lymphoma-non-hodgkin, lymphoma-t-cell-cutaneous, lymphoproliferative-disorders, malignant-neoplasms, malignant-paraganglionic-neoplasm, marginal-zone-b-cell-lymphoma, mycoses, mycosis-fungoides, neoplasms, primary-cutaneous-lymphoma, pseudolymphoma, skin-neoplasms, t-cell-lymphoma.
Among the many pathways, these few ones have gauged particular interests from scientists studying Primary Cutaneous B-cell Lymphoma, and have been seen in publications frequently: Cell Division, Cell Proliferation, Dna Amplification, Hormone Secretion, Hypersensitivity, Immune Response, Localization, Lymphocyte Differentiation, Lymphocyte Proliferation, P38mapk Cascade, Pathogenesis, Response To Antibiotic, Response To Radiation, Secretion
Quite a number of genes have been found to play important roles in Primary Cutaneous B-cell Lymphoma, such as BCL2, BCL6, CD5, CD79A, CDKN2A, CTLA4, HLA-DQA1, IRF4, JUN, JUNB, KRT20, LTA, MME, MS4A1, NOD2, PKD2L1, SPN, TSPYL2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.